Quality control ranges for cefoperazone 30μg disks for Staphylococcus aureus ATCC® 25923 and Escherichia coli ATCC® 25922

Veterinary Microbiology

Volumn 171, Issue 3-4, 2014, Pages 284-289

  Feßler, Andrea T ^a   Turnidge, John ^b   Schwarz, Stefan ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

3rd generation cephalosporins; Bovine mastitis; Susceptibility testing; Zone diameter

Indexed keywords

AGAR; CEFOPERAZONE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; ESCHERICHIA COLI; LABORATORY; NONHUMAN; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; ANIMAL; BOVINAE; DISK DIFFUSION; DRUG EFFECTS; FEMALE; MASTITIS, BOVINE; STANDARDS;

BOVINAE; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

ANIMALS; CATTLE; CEFOPERAZONE; DISK DIFFUSION ANTIMICROBIAL TESTS; ESCHERICHIA COLI; FEMALE; MASTITIS, BOVINE; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS;

EID: 84901925412     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.02.039     Document Type: Article

References (11)

1. ® 25923. J. Antimicrob. Chemother. 2014, 69:277-280.
2. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-first Informational Supplement. CLSI Document M100-S23 2013, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
3. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard - Fourth edition. CLSI document VET01-A4 2013, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
4. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Second Informational Supplement. CLSI Document VET01-S2 2013, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
5. Clinical and Laboratory Standards Institute (CLSI) Generation, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report - First edition. CLSI Document VET05-R (Formerly X-08-R) 2011, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
6. Clinical and Laboratory Standards Institute (CLSI) Development of in vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline - Third edition. CLSI Document VET02-A3 (Formerly M37-A3) 2008, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
7. Feßler A.T., Kaspar H., Lindeman C.J., Stegemann M.R., Peters T., Mankertz J., Watts J.L., Schwarz S. A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens. Vet. Microbiol. 2012, 157:226-231.
8. Jones R.N., Gavan T.L., Barry A.L., Thornsberry C., Gibbs D.L. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance and determination of quality control performance limits. J. Clin. Microbiol. 1982, 15:777-786.
9. Schwarz S., Silley P., Simjee S., Woodford N., van Duijkeren E., Johnson A.P., Gaastra W. Assessing the antimicrobial susceptibility of bacteria obtained from animals. Vet. Microbiol. 2010, 141:1-4.
10. Thornsberry C., Barry A.L., Jones R.N., Baker C.N., Badal R.E. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone. J. Clin. Microbiol. 1982, 15:769-776.
11. Turnidge J., Bordash G. Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing. Antimicrob. Agents Chemother. 2007, 51:2483-2488.